Having leverage with its proprietary cell sheet engineering platform technology1, Cellseed is going to commercialize two products for which the regenerative medicine market has hardly waited. hardly waited for Venture Valuation (VV) interviewed the CEO, Dr. Setsuko Hashimoto Read the interview
Pioneering research on biomolecular diffusion in nanofluidics, Abionic has developed the abioSCOPE, an in-vitro platform performing quantitative diagnostic testing. Its first application products: abioKIT Total IgE (1 test in 5min) and abioKIT Aeroallergens (6 tests in 12 min) are now available in the POC diagnostic market in Europe, and in 2016 in the U.S. Venture … Continue reading Interviews with leading Life Sciences companies: Abionic SA
Interviews with leading Life Sciences companies: Wastec, Inc. Wastec, Inc. – English – 3 pages – 796kb
Interviews with leading Life Sciences companies: Futaku Precision Machinery Industry Co. Futaku Precision Machinery Industry Co. – English – 3 pages – 1mb
Interviews with leading Life Sciences companies Nakamura Brace Co.,Ltd. Nakamura Brace Co Ltd – Japanese – 4 pages – 360 kb
Interviews with leading Life Sciences companies Nakamura Brace Co.,Ltd. Nakamura Brace Co Ltd – English – 4 pages – 258 kb
Interviews with leading Life Sciences companies: Interprotein Corporation English (PDF) – 3 pages – 680kb
Interviews with leading Life Sciences companies: AVA-CO2 Schweiz AG English (PDF) – 4 pages – 1001kb
Interviews with leading Life Sciences companies: Next Energy & Resouces Co. Ldt. English (PDF) – 3 pages – 791kb
Interviews with leading Life Sciences companies: Mebiol Inc English (PDF) – 4 pages – 331kb
